High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori eradication

Helicobacter

Volumn 6, Issue 2, 2001, Pages 157-162

  Gisbert, Javier P ^a   Marcos, Santiago ^b   Gisbert, Jose Luis ^b   Pajares, Jose Maria ^a,b  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b NONE   (Spain)

Author keywords

Amoxicillin; Clarithromycin; Helicobacter pylori; Metronidazole; Ranitidine bismuth citrate; Therapy

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; RANITIDINE BISMUTH CITRATE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DYSPEPSIA; ERADICATION THERAPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; NAUSEA AND VOMITING; PATIENT COMPLIANCE; PRIORITY JOURNAL; TASTE DISORDER; TREATMENT OUTCOME;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BISMUTH; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; RANITIDINE;

HELICOBACTER PYLORI; NEGIBACTERIA;

EID: 0034960643     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5378.2001.00023.x     Document Type: Article

References (41)

1. Current European concepts in management of Helicobacter pylori infection. The Maastricht Consensus Report
2. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection
3. Treatment for the eradication of Helicobacter pylori. Recommendations of the Spanish Consensus Conference
4. 13C-urea breath test for the detection of Helicobacter pylori
5. 13C-urea breath test for diagnosis of H. pylori infection
6. Proton pump inhibitor, clarithromycin and either amoxicillin or nitroimidazole: A meta-analysis of eradication of Helicobacter pylori
7. Evaluation of treatment regimens to cure Helicobacter pylori infection-a meta-analysis
8. Review article: One-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori
9. The importance of clarithromycin dose in the management of Helicobacter pylori infection: A meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole
10. What other regimens are under investigation to treat Helicobacter pylori infection?
11. The success of short-course treatment regimens for Helicobacter pylori infections is strongly influenced by pre-treatment antimicrobial susceptibility
12. The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen
13. Omeprazole plus 2 antibiotics for the eradication of H. pylori, are 5 days of treatment sufficient?
14. Lansoprazole triple therapy for Helicobacter pylori is 5 days enough?
15. Amoxicillin/metronidazole/omeprazole/clarithromycin: A new, short quadruple therapy for Helicobacter pylori eradication
16. The impact of clinical factors on the outcome of a new short term H. pylori eradication scheme
17. Impact of treatment duration and metronidazole resistance on H. pylori cure with omeprazole, metronidazole, and clarithromycin
18. Ranitidine bismuth citrate
19. Ranitidine bismuth citrate therapy regimens for treatment of H. pylori infection: A review
20. One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication
21. Helicobacter pylori eradication: Proton pump inhibitor versus ranitidine bismuth citrate plus two antibiotics for 1 week - A meta-analysis of efficacy
22. The role of ranitidine bismuth citrate in significantly reducing the emergence of Helicobacter pylori strains resistant to antibiotics
23. Study of the combination of ranitidine bismuth citrate and metronidazole against metronidazole-resistant Helicobacter pylori clinical isolates
24. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: A randomized, clinical trial
25. One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: The RBC-MACH study
26. The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection
27. A systematic review of Helicobacter pylori eradication therapy-the impact of antimicrobial resistance on eradication rates
28. How long for the routine Helicobacter pylori antimicrobial susceptibility testing? The usefulness of the string test to obtain Helicobacter for culture
29. Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: A prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer
30. Helicobacter pylori resistance to metronidazole and clarithromycin in Spain. A systematic review
31. Is twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H. pylori infection in peptic ulcer and in non-ulcer dyspepsia?
32. Is there any difference in Helicobacter pylori eradication rates in patients with active peptic ulcer, inactive peptic ulcer and functional dyspepsia?
33. Duodenal ulcer and functional dyspepsia: Different susceptibility of Helicobacter pylori to eradicating therapy
34. Efficacy and tolerability of a seven-day triple scheme with pantoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori
35. Efficacy of PPI-triple therapy in H. pylori positive patients with ulcer disease versus patients with non-ulcer dyspepsia
36. Different Helicobacter pylori eradication rates between non-ulcer dyspepsia and peptic ulcer patients
37. Efficacy of one week pantoprazole containing triple therapies for eradication of Helicobacter pylori
38. Is PPI-triple therapy of greater efficacy in peptic ulcer than in non-ulcer dyspeptic patients
39. Does the efficacy of eradication treatment with OCA-7 decrease in non-ulcer gastroduodenal disease?
40. Omeprazole plus antibiotics in the eradication of H. pylori infection: A meta-regression analysis of randomized, controlled trials
41. Are one-week anti-H. pylori treatments more effective in patients with peptic ulcer disease (PUD) than in those with non-ulcer dyspepsia (NUD)? A meta-analysis